Source: Eur Respir Rev, 30 (159) 190185; 10.1183/16000617.0185-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Xiaofan Tu, Chantal Donovan, Richard Y. Kim, Peter A.B. Wark, Jay C. Horvat, Philip M. Hansbro. Asthma-COPD overlap: current understanding and the utility of experimental models. Eur Respir Rev, 30 (159) 190185; 10.1183/16000617.0185-2019

Member's Comments

No comment yet.

Related content which might interest you: Asthma-COPD overlap syndrome (ACOS): a comparison between five different classification models Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006 The disease model: implications for clinical practice Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018 Year: 2018 Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease Year: 2007 Different definitions in childhood asthma: how dependable is the dependent variable? Source: Eur Respir J 2010; 36: 48-56 Year: 2010 Device-generated data: current knowledge and perspectives Source: 5th Sleep and Breathing Conference Year: 2019 Asthma-COPD overlap syndrome: prevalence and clinical characteristics Source: International Congress 2017 – Management of asthma in different situations Year: 2017 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 The development of equations to describe normal values: the past and current insights from the GLI project Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021 Some current challenges in statistical methods to illuminate disease genetics Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 How to translate findings from experimental models into clinical studies in OSA Source: Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases Year: 2019 Developing a chronic murine model that better reflects the clinical features of the human asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds Source: Eur Respir J 2006; 27: 9-11 Year: 2006 The evaluation of frequency dependence of resistance using a patient-specific 3D physical model and a computational model Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Which modelling methodology is best? Source: ERS Research Seminar 2017 – The impact of air pollution on respiratory health Year: 2018 Laboratory investigations of infection in COPD: current best practice and future possibilities Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008